2019 Epitranscriptomic regulation of HIV-1 gene expression by m5C and the novel m5C reader MBD2. Annual Meeting of the RNA Society on 11-16 June, Krakow, Poland. Poster presentation.

2018 Epitranscriptomic enhancement of influenza A virus gene expression and replication. American Society of Virology Annual Meeting on 14-18 July, College Park, MD, USA. Oral presentation.

2018 NSUN2 as a writer of m5C on HIV RNA. Structural Biology Related to HIV/AIDS on 28-29 June, Bethesda, MD, USA. Poster presentation.

2017 Epitranscriptomic enhancement of influenza A virus gene expression and replication. 1st Symposium on Nucleic Acid Modifications on 4-6 September, Mainz, Germany. Poster presentation.

2017 Epitranscriptomic enhancement of influenza A virus gene expression and replication. Nucleic Acids & Immunity, RNA Society satellite meeting on 4-7th June Brno, Czech Republic. Oral presentation

2015 The development of allele-specific CRISPR/Cas9 based therapeutics for corneal disorders. Genome Engineering: The CRISPR/Cas Revolution on 24-27^th September, Cold Spring Harbor Lab, USA. Poster presentation.

2015 Novel allele-specific cleavage of mutant KRT12 in vitro and in vivo by CRISPR/Cas9 through the utilisation of a SNP-derived PAM. EMBO Annual Meeting on 8^th September, Birmingham, UK. Oral & Poster presentation.

2015 Composition of corneal stromal aggregates associated with Lattice and Granular type 1 variants of TGFBI related corneal dystrophies. Vision Translational Research Group Meeting on 20^th February, Belfast, UK. Poster presentation.

2014 Use of gene therapy tools to determine the role of MMPs in lattice corneal dystrophy type I. EU Cornea on 13^th September, London, UK. ePoster.

2014 Development of personalized therapeutics for lattice corneal dystrophy type I. European Society of Human Genetics Annual Meeting on 2nd June, Milan, Italy. Poster presentation.

2014 Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I. The Association for Research in Vision and Ophthalmology Annual Meeting on 7th May, Orlando, USA. Oral presentation.

2014 Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I. Vision Translational Research Group Meeting on 14^th March, Belfast, UK. Oral presentation.

2014 Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I. Northern Ireland Infection & Immunity Translational Research Group Meeting on 25th February, Belfast, UK. Oral presentation.

2013 Identifying Potent and Specific siRNAs for Allele Specific Gene Silencing in Diseases Following a Dominant Negative Pathomechanism. BIT’s World Gene Convention on 14th November, Haikou, China. Oral presentation.

2013 Assessment of allele-specific gene silencing siRNAs in an ex vivo pre-clinical model of lattice type I corneal dystrophy. Irish Society of Human Genetics Scientific Meeting on 6th September, Belfast, UK. Oral presentation.